L367-0495 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

L367-0495 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide
L367-0495 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L367-0495
4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L367-0495

Molecular Formula

C27H31N5O2 (C27 H31 N5 O2)

Compound Name

4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

IUPAC name

4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[4-(morpholin-4-yl)phenyl]benzamide

SMILES

O=C(c(cc1)ccc1-c1cnc(NC2CCCCC2)nc1)Nc(cc1)ccc1N1CCOCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.568

Distribution Coefficient, logD

4.567

Water Solubility, LogSw

-4.36

Polar Surface Area

65.128

Acid Dissociation Constant (pKa)

11.11

Base Dissociation Constant (pKb)

6.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

L367-0495 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Lipid Metabolism Library (9174 compounds)

PI3K-Targeted Library (17255 compounds)

Proline Kinase Library (2105 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L367-0495 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L367-0495?
Check Price and Availability of L367-0495, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L367-0495 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L367-0495
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L367-0495
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L367-0495 available by request